Citation Tools

Download PDFPDF
1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study

Download to a citation manager

Cite this article as:
Giudice E, Vertechy L, Iannantuono GM, et al
1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study